Sign In
Buy AXSM
$233.49
+11.33 (+5.10%)
At Close: Jun 03, 2026
Axsome Therapeutics Just Took Its Key Moving Averages — Here's Why
11:21am, Monday, 27'th Jun 2022
The Food and Drug Administration could be nearing a decision on Axsome Therapeutics' depression treatment, and AXSM stock rocketed Monday. The post Axsome Therapeutics Just Took Its Key Moving Average
Axsome Therapeutics Stock Surges on FDA Update
10:49am, Monday, 27'th Jun 2022
Axsome Therapeutics Inc (NASDAQ:AXSM) is surging today, after the company said it has received proposed labeling from the Food and Drug Administration (FDA) for AXS-05, its drug candidate to treat
Axsome Therapeutics (AXSM) Stock Soars on FDA Labeling Proposal
10:20am, Monday, 27'th Jun 2022
Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs. The post Axsome Therapeutics (AXSM) Stock Soars on FDA Labelin
Tesla's Up as Stock-Split Investors Wait, But This Tiny Nasdaq Stock Is Riding High Monday
09:18am, Monday, 27'th Jun 2022
A tiny biotech company got great news to start off the week.
Why Axsome Therapeutics Stock Is On Fire Today
09:16am, Monday, 27'th Jun 2022
The biotech appears to be close to securing final approval for its major depressive disorder drug.
Why Axsome Therapeutics Stock Is Soaring Today
08:52am, Monday, 27'th Jun 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressiv
3 Stocks That Could Double by 2025
05:58am, Sunday, 19'th Jun 2022
These companies have realistic prospects of achieving tremendous growth.
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
05:11pm, Friday, 03'rd Jun 2022
Biotech investors stand to make a windfall if they make calculated bets by thoroughly researching on key catalysts that could move the stocks in a big way. The post 6 Biotech Stocks to Buy Now Ahead o
Why Is Axsome (AXSM) Down 30.3% Since Last Earnings Report?
01:33pm, Wednesday, 01'st Jun 2022
Axsome (AXSM) reported earnings 30 days ago. What's next for the stock?
Is This Biotech a Safe Stock to Buy?
06:15am, Saturday, 14'th May 2022
It recently got a major green light from regulators.
My Favorite Biotech
04:00pm, Friday, 13'th May 2022
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
Why Axsome Therapeutics Stock Got Mashed on Monday
05:46pm, Monday, 09'th May 2022
Investors were hardly impressed with the closing of a rights deal.
JAZZ Q1 Earnings Miss, Sales Robust, 2022 Guidance Raised
12:02pm, Thursday, 05'th May 2022
JAZZ's product revenues grow in the first quarter on the back of strong demand for its new drugs and drugs added with the acquisition of GW Pharmaceuticals. It raises guidance on strong results.
Why Axsome (AXSM) is Up 7% Despite Wider-Than-Expected Q1 Loss
12:02pm, Tuesday, 03'rd May 2022
Axsome (AXSM) reports a slightly wider-than-estimated Q1 loss. It expects to receive FDA approval for its lead candidate AXS-05 by second-quarter 2022 to treat major depressive disorder.
Axsome Therapeutics, Inc.'s (AXSM) CEO Herriot Tabuteau on Q1 2022 Results - Earnings Call Transcript
12:05pm, Monday, 02'nd May 2022
Axsome Therapeutics, Inc. (NASDAQ:AXSM ) Q1 2022 Earnings Conference Call May 2, 2022 8:00 AM ET Company Participants Mark Jacobson - Chief Operating Officer Herriot Tabuteau - Chief Executive Officer
